As of Apr 21
| -0.12 / -0.28%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 46.37, with a high estimate of 55.09 and a low estimate of 36.00. The median estimate represents a +8.54% increase from the last price of 42.72.
The current consensus among 32 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.